Literature DB >> 30080204

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis.

Guadalupe Tirma González-Mateo1, Lucía Pascual-Antón2, Pilar Sandoval2, Abelardo Aguilera Peralta3, Manuel López-Cabrera2.   

Abstract

Peritoneal dialysis (PD) is a renal replacement therapy consistent on the administration and posterior recovery of a hyperosmotic fluid in the peritoneal cavity to drain water and toxic metabolites that functionally-insufficient kidneys are not able to eliminate. Unfortunately, this procedure deteriorates the peritoneum. Tissue damage triggers the onset of inflammation to heal the injury. If the injury persists and inflammation becomes chronic, it may lead to fibrosis, which is a common occurrence in many diseases. In PD, chronic inflammation and fibrosis, along with other specific processes related to these ones, lead to ultrafiltration capacity deterioration, which means the failure and subsequent cessation of the technique. Working with human samples provides information about this deterioration but presents technical and ethical limitations to obtain biopsies. Animal models are essential to study this deterioration since they overcome these shortcomings. A chronic mouse infusion model was developed in 2008, which benefits from the wide range of genetically modified mice, opening up the possibility of studying the mechanisms involved. This model employs a customized device designed for mice, consisting of a catheter attached to an access port that is placed subcutaneously at the back of the animal. This procedure avoids continuous puncture of the peritoneum during long-term experiments, reducing infections and inflammation due to injections. Thanks to this model, peritoneal damage induced by chronic PD fluid exposure has been characterized and modulated. This technique allows the infusion of large volumes of fluids and could be used for the study of other diseases in which inoculation of drugs or other substances over extended periods of time is necessary. This article shows the method for the surgical placement of the catheter in mice. Moreover, it explains the procedure for a 5/6 nephrectomy to mimic the state of renal insufficiency present in PD patients.

Entities:  

Mesh:

Year:  2018        PMID: 30080204      PMCID: PMC6126517          DOI: 10.3791/56746

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  42 in total

1.  Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.

Authors:  An S De Vriese; Ronald G Tilton; Siska Mortier; Norbert H Lameire
Journal:  Nephrol Dial Transplant       Date:  2006-06-06       Impact factor: 5.992

Review 2.  Uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

3.  Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.

Authors:  Abelardo Aguilera; Maria Yáñez-Mo; Rafael Selgas; Francisco Sánchez-Madrid; Manuel López-Cabrera
Journal:  Curr Opin Investig Drugs       Date:  2005-03

4.  Influence of sodium withdrawal by a diuretic agent or peritoneal dialysis on arterial pressure in one-kidney Goldblatt hypertension in the rat.

Authors:  J F Liard
Journal:  Pflugers Arch       Date:  1973-11-26       Impact factor: 3.657

5.  A new non-uremic rat model of long-term peritoneal dialysis.

Authors:  Y-M Peng; Z-J Shu; L Xiao; L Sun; W-B Tang; Y Huang; Y-H Liu; J Li; G-H Ling; X-Q Xu; U Halmurat; F-Y Liu
Journal:  Physiol Res       Date:  2010-10-15       Impact factor: 1.881

6.  Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.

Authors:  Yanyan Sun; Fengxin Zhu; Xueqing Yu; Jing Nie; Fengxian Huang; Xiaoyan Li; Ning Luo; Hui Yao Lan; Yongtao Wang
Journal:  Am J Nephrol       Date:  2009-02-18       Impact factor: 3.754

7.  Bicarbonate- versus lactate-based CAPD fluids: a biocompatibility study in rabbits.

Authors:  H T Schambye; P Flesner; R B Pedersen; M Hardt-Madsen; J Chemnitz; H K Christensen; A Detmer; F B Pedersen
Journal:  Perit Dial Int       Date:  1992       Impact factor: 1.756

8.  Peritoneal Dialysis.

Authors:  R A Pyper
Journal:  Ulster Med J       Date:  1948-11

9.  Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.

Authors:  Guadalupe T González-Mateo; Vanessa Fernández-Míllara; Teresa Bellón; Georgios Liappas; Marta Ruiz-Ortega; Manuel López-Cabrera; Rafael Selgas; Luiz S Aroeira
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

10.  Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.

Authors:  Jesús Loureiro; Pilar Sandoval; Gloria del Peso; Guadalupe Gónzalez-Mateo; Vanessa Fernández-Millara; Beatríz Santamaria; Maria Auxiliadora Bajo; José Antonio Sánchez-Tomero; Gonzalo Guerra-Azcona; Rafael Selgas; Manuel López-Cabrera; Abelardo I Aguilera
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more
  1 in total

1.  Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid.

Authors:  Valeria Kopytina; Lucía Pascual-Antón; Nora Toggweiler; Eva-María Arriero-País; Lisa Strahl; Patricia Albar-Vizcaíno; David Sucunza; Juan J Vaquero; Sonja Steppan; Dorothea Piecha; Manuel López-Cabrera; Guadalupe-Tirma González-Mateo
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.